Citations

Clear

334 citation(s) found for "Jacobs, C".

Choosing Ceftazidime/Avibactam and Ceftolozane/Tazobactam as Empiric Therapies against Pseudomonas aeruginosa (Pa) using Rapid Molecular Diagnostics (RMDs): PRIMERS IV
Tran, Thuy Tien T., Hujer, Andrea M. , Hill, Carol , Hujer, Kristine M., Mediavilla, José R. , Kreiswirth, Barry N , Pérez, Federico , Sampath, Rangarajan , Marzan, Christine, Fowler, Vance G. , Chambers, Henry F. , Evans, Scott , Manca, Claudia , Domitrovic, Tatiana , Patel, Robin , Jacobs, Michael R. , Chen, Liang , Hall, Thomas, Fowler, Vance G. , Bonomo, Robert A.

Mayo Clinic

Open Forum Infectious Diseases | February 1, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw172.1598 Get It

Workshop on imaging science development for cancer prevention and preemption
Kelloff, Gary J. , Sullivan, Daniel C. , Baker, Houston, Clarke, Lawrence, Nordstrom, Robert J. , Tatum, James L. , Dorfman, Gary S., Berg, Christine D. , Birrer, Michael J. , Tempero, Margaret A. , Higley, Howard R., Petty, Brenda Gumbs, Sigman, Caroline C. , Ginsberg, Gregory G. , Dannenberg, Andrew J. , Hawk, Ernest T. , Messing, Edward M. , Grossman, H. Barton, Griebel, Donna, Henson, Donald E., Fabian, Carol J. , Zujewski, Jo Anne , Hayes, Wendy, Klein, Eric A. , Ocak, İclal , Tempany, Clare M. , Shtern, Faina, Parnes, Howard L. , Gómez, Jorge , Srivastava, Sudhir , Lam, Stephen , Seibel, Eric J. , Massion, Pierre P. , McLennan, Geoffrey, Burt, Randall W., Hoffman, John M. , El‐Deiry, Wafik S. , Papadimitrakopoulou, Vali, Veltri, Robert W., Solomon, Diane, Viner, Jaye L., Stratton, Steven P. , Rajadhyaksha, Milind , Dhawan, Atam P. , Jacobs, Paula , Pomper, Martin G. , Maley, Carlo C. , Sharma, Prateek , Wax, Adam , Harisinghani, Mukesh G. , Bigio, Irving J. , Ferrara, Katherine W. , Fantini, Sergio , Schnall, Mitchell D. , Zujewski, Jo Anne , Marzo, Angelo M. De , Ketterling, Jeffrey A. , Szabó, Éva , Cleary, Kevin , Suh, Robert D. , Pfeiffer, Ruth M. , Roy, Hemant K. , Wang, Thomas J. , Limburg, Paul J. , Hittelman, Walter N. , MacAulay, Calum E. , Jerónimo, José , Richards‐Kortum, Rebecca , Johnson, Karen A. , Klein, Eric A

Mayo Clinic

Cancer Biomarkers | January 31, 2017 | Volume: 3 | Issue: 1 | Pages: 1-33

10.3233/cbm-2007-3101 | PMID 17655039 Get It

Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III
Hujer, Andrea M. , Jiang, Hongyu , Hill, Carol , Hujer, Kristine M., Mediavilla, José R. , Tran, Thuy Tien T., Higgins, Paul G. , Kreiswirth, Barry N. , Patel, Robin , Chen, Liang , Sampath, Rangarajan , Marzan, Christine, Fowler, Vance G. , Chambers, Henry F. , Sampath, Rangarajan , Evans, Scott , Manca, Claudia , Domitrovic, Tatiana , Seifert, Harald , Kreiswirth, Barry N , Jacobs, Michael R. , Chen, Liang , Hall, Thomas A. , Fowler, Vance G. , Bonomo, Robert A. , Patel, Robin , Evans, Scott R

Mayo Clinic

Journal of Clinical Microbiology | October 26, 2016 | Volume: 55 | Issue: 1 | Pages: 134-144

10.1128/jcm.01524-16 | PMID 27795336 Get It

ABSTRACT The widespread dissemination of carbapenem-resistant Acinetobacter spp. has created significant therapeutic challenges. At present, rapid molecular diagnostics (RMDs) that can identify this phenotype are not commercially available. Two RMD platforms, PCR combined with electrospray ionization mass spectrometry (PCR/ESI-MS) and molecular beacons (MB), for detecting genes conferring resistance/susceptibility to carbapenems in Acinetobacter spp. were evaluated. An archived collection of 200 clinical Acinetobacter sp. isolates was tested. Predictive values for susceptibility and resistance were estimated as a function of susceptibility prevalence and were based on the absence or presence of beta-lactamase ( bla ) NDM, VIM, IMP, KPC, and OXA carbapenemase genes (e.g., bla OXA-23 , bla OXA-24/40 , and bla OXA-58 found in this study) against the reference standard of MIC determinations. According to the interpretation of MICs, 49% ( n = 98) of the isolates were carbapenem resistant (as defined by either resistance or intermediate resistance to imipenem). The susceptibility sensitivities (95% confidence interval [CI]) for imipenem were 82% (74%, 89%) and 92% (85%, 97%) for PCR/ESI-MS and MB, respectively. Resistance sensitivities (95% CI) for imipenem were 95% (88%, 98%) and 88% (80%, 94%) for PCR/ESI-MS and MB, respectively. PRIMERS III establishes that RMDs can discriminate between carbapenem resistance and susceptibility in Acinetobacter spp. In the context of a known prevalence of resistance, SPVs and RPVs can inform clinicians regarding the best choice for empiric antimicrobial therapy against this multidrug-resistant pathogen.
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21
Wang, Zhaoming , Obazee, Ofure , Jia, Jinping , Childs, Erica J., Hoskins, Jason W. , Figlioli, Gisella , Collins, Irene , Chung, Charles C., Hautman, Christopher, Arslan, Alan A. , Bracci, Paige M. , Buring, Julie E. , Gallinger, Steven , Goodman, Gary E. , Goodman, Phyllis J. , Kamineni, Aruna , Kolonel, Laurence N. , Kulke, Matthew H. , Malats, Núria , Olson, Sara H. , Sesso, Howard D. , Visvanathan, Kala , Zheng, Wei , Abnet, Christian C. , Andreotti, Gabriella , Bueno-de-Mesquita, H. Bas, Basso, Daniela , Berndt, Sonja I. , Brenner, Hermann , Burdette, Laurie , Campa, Daniele , Caporaso, Neil E. , Capurso, Gabriele , Cavestro, Giulia Martina , Costello, Eithne , Elena, Joanne W. , Boggi, Ugo , Gaziano, J. Michael , Giovannucci, Edward L. , Gross, Myron D., Haiman, Christopher A. , Hassan, Manal M. , Helzlsouer, Kathy J., Hu, Nan , Hunter, David J., Iskierka‐Jazdzewska, Elżbieta , Jenab, Mazda , Klein, Eric A. , Krogh, Vittorio , Kupčinskas, Juozas , Kurtz, Robert C. , Landi, Maria Teresa , Mambrini, Andrea , Neale, Rachel Ε. , Oberg, Ann L. , Patel, Alpa V. , Peeters, Petra H., Peters, Ulrike , Pezzilli, Raffaele , Porta, Miquel , Purdue, Mark P. , Quirós, J. Ramón , Ríboli, Elio , Rothman, Nathaniel , Scarpa, Aldo , Scélo, Ghislaine , Strobel, Oliver , Małecka‐Panas, Ewa , Tavano, Francesca , Travis, Ruth C. , Thornquist, Mark, Tjønneland, Anne , Trichopoulos, Dimitrios, Vashist, Yogesh K. , Vodička, Pavel , Wactawski‐Wende, Jean , Wentzensen, Nicolas , Yu, Kai , Zeleniuch‐Jacquotte, Anne , Jacobs, Eric J. , Li, Donghui , Fuchs, Charles S. , Hoover, Robert N. , Hartge, Patricia, Petersen, Gloria M. , Stolzenberg-Solomon, Rachael S., Wolpin, Brian M. , Kraft, Peter , Canzian, Federico , Ámundadóttir, Laufey T. , Zhang, Mingfeng , Mocci, Evelina , Freeman, Laura E. Beane , Duell, Eric J. , Giles, Graham G. , White, Emily , Albanes, Demetrius , Brais, Lauren K , Boutron‐Ruault, Marie‐Christine , Bijlsma, Maarten F. , Cotterchio, Michelle , Gazouli, Maria , Goggins, Michael , Kaaks, Rudolf , Key, Tim , Khaw, Kay‐Tee , Kogevinas, Manolis , Kupcinskas, Juozas , Landi, Stefano , Marchand, Loı̈c Le , Männistö, Satu , Milne, Roger L. , Panico, Salvatore , Shu, Xiao‐Ou , Silverman, Debra T. , Souček, Pavel , Sund, Malin , Taylor, Philip R. , Tobias, Geoffrey S. , Yu, Kai , Kooperberg, Charles , Risch, Harvey A. , Chanock, Stephen Jacob , Klein, Alison P. , Amundadottir, Laufey , Malats, Nuria , Arslan, Alan A , Canzian, Federico , Tjønneland, Anne , Wactawski-Wende, Jean , Travis, Ruth C , Wang, Zhaoming , Abnet, Christian C , Visvanathan, Kala , Klein, Eric A , Brenner, Hermann , Strobel, Oliver , Jenab, Mazda , Kraft, Peter , Zheng, Wei , Iskierka-Jazdzewska, Elżbieta , Riboli, Elio , Vodicka, Pavel , Neale, Rachel E , Porta, Miquel , Zeleniuch-Jacquotte, Anne , Hoskins, Jason W , Tavano, Francesca

Mayo Clinic

Oncotarget | September 16, 2016 | Volume: 7 | Issue: 41 | Pages: 66328-66343

10.18632/oncotarget.11041 | PMID 27579533 Get It

Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes
Thompson, Patricia A. , Ashbeck, Erin L., Roe, Denise J. , Fales, Liane, Buckmeier, Julie A., Wang, Fang , Bhattacharyya, A. K. , Hsu, Chiu‐Hsieh , Chow, H.‐H. Sherry , Ahnen, Dennis J. , Heigh, Russell I., Fay, David E., Jacobs, Elizabeth T. , Alberts, David S., Lance, Peter , Buckmeier, Julie, Bhattacharyya, Achyut, Boland, C. Richard , Hamilton, Stanley R. , Martı́nez, Marı́a Elena

Mayo Clinic

JNCI: Journal of the National Cancer Institute | August 17, 2016 | Volume: 108 | Issue: 12 | Pages: No page available

10.1093/jnci/djw152 | PMID 27530657 Get It

Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial
Thompson, Patricia A. , Ashbeck, Erin L., Roe, Denise J. , Fales, Liane, Buckmeier, Julie A., Wang, Fang , Bhattacharyya, Achyut, Hsu, Chiu‐Hsieh , Chow, Sherry, Ahnen, Dennis J. , Heigh, Russell I., Fay, David E., Jacobs, Elizabeth T. , Alberts, David S., Lance, Peter , Buckmeier, Julie, Chow, Sherry H H, Boland, C. Richard , Hamilton, Stanley R. , Martinez, Elena Maria, Martínez, Elena

Mayo Clinic

JNCI: Journal of the National Cancer Institute | August 16, 2016 | Volume: 108 | Issue: 12 | Pages: No page available

10.1093/jnci/djw151 | PMID 27530656 Get It

Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology
Ahmed, A. Razzaque, Carrozzo, M , Cirillo, Nicola , Dmochowski, Marian , Alonso, A. España, Gniadecki, Robert , López-Zabalza, Marı́a J. , Lotti, Roberta , Pincelli, Carlo , Pittelkow, Mark R. , Schmidt, Enno , Sprecher, Eli , Grando, Sergei A. , Caux, Frédéric , Hertl, Michael , Sinha, Animesh A. , Schmidt, Enno

Mayo Clinic

Experimental Dermatology | June 15, 2016 | Volume: 25 | Issue: 11 | Pages: 839-846

10.1111/exd.13106 | PMID 27305362 Get It

AbstractThis viewpoint highlights major, partly controversial concepts about the pathogenesis of pemphigus. The monopathogenic theory explains intra‐epidermal blistering through the “desmoglein (Dsg) compensation” hypothesis, according to which an antibody‐dependent disabling of Dsg 1‐ and/or Dsg 3‐mediated cell–cell attachments of keratinocytes (KCs) is sufficient to disrupt epidermal integrity and cause blistering. The multipathogenic theory explains intra‐epidermal blistering through the “multiple hit” hypothesis stating that a simultaneous and synchronized inactivation of the physiological mechanisms regulating and/or mediating intercellular adhesion of KCs is necessary to disrupt epidermal integrity. The major premise for a multipathogenic theory is that a single type of autoantibody induces only reversible changes, so that affected KCs can recover due to a self‐repair. The damage, however, becomes irreversible when the salvage pathway and/or other cell functions are altered by a partnering autoantibody and/or other pathogenic factors. Future studies are needed to (i) corroborate these findings, (ii) characterize in detail patient populations with non‐Dsg‐specific autoantibodies, and (iii) determine the extent of the contribution of non‐Dsg antibodies in disease pathophysiology.
Risk Factor Profile in Parkinson’s Disease Subtype with REM Sleep Behavior Disorder
Jacobs, Marie L. , Dauvilliers, Yves , Louis, Erik K. St. , McCarter, Stuart J. , Romenets, Silvia Ríos, Pelletier, Amélie , Cherif, Mahmoud, Gagnon, Jean‐François, St Louis, Erik K, Cherif, Mahmoud, Postuma, Ronald B. , St Louis, E K , Dauvilliers, Yves , McCarter, Stuart J

Mayo Clinic

Journal of Parkinson’s Disease | April 6, 2016 | Volume: 6 | Issue: 1 | Pages: 231-237

10.3233/jpd-150725 | PMID 26889635 Get It

Background: Numerous large-scale studies have found diverse risk factors for Parkinson’s disease (PD), including caffeine non-use, non-smoking, head injury, pesticide exposure, and family history. These studies assessed risk factors for PD overall; however, PD is a heterogeneous condition. One of the strongest identifiers of prognosis and disease subtype is the co-occurrence of rapid eye movement sleep behavior disorder (RBD). In previous studies, idiopathic RBD was associated with a different risk factor profile from PD and dementia with Lewy bodies, suggesting that the PD-RBD subtype may also have a different risk factor profile. Objective: To define risk factors for PD in patients with or without associated RBD. Methods: In a questionnaire, we assessed risk factors for PD, including demographic, medical, environmental, and lifestyle variables of 189 PD patients with or without associated polysomnography-confirmed RBD. The risk profile of patients with vs. without RBD was assessed with logistic regression, adjusting for age, sex, and disease duration. Results: PD-RBD patients were more likely to have been a welder (OR = 3.11 (1.05–9.223), and to have been regular smokers (OR = 1.96 (1.04–3.68)). There were no differences in use of caffeine or alcohol, other occupations, pesticide exposure, rural living, or well water use. Patients with RBD had a higher prevalence of the combined family history of both dementia and parkinsonism (13.3% vs. 5.5% , OR = 3.28 (1.07–10.0). Conclusion: The RBD-specific subtype of PD may also have a different risk factor profile.
Appending Limited Clinical Data to an Administrative Database for Acute Myocardial Infarction Patients
Samadashvili, Zaza, Cozzens, Kimberly , Venditti, Ferdinand J. , Holmes, David R. , Berger, Peter B. , Stamato, Nicholas J., Walford, Gary, Hannan, Edward L. , Jacobs, Alice K. , Hughes, Suzanne C.

Mayo Clinic

Medical Care | February 25, 2016 | Volume: 54 | Issue: 5 | Pages: 538-545

10.1097/mlr.0000000000000520 | PMID 27078825 Get It

Background: Hospitals’ risk-standardized mortality rates and outlier status (significantly higher/lower rates) are reported by the Centers for Medicare and Medicaid Services (CMS) for acute myocardial infarction (AMI) patients using Medicare claims data. New York now has AMI claims data with blood pressure and heart rate added. Objective: The objective of this study was to see whether the appended database yields different hospital assessments than standard claims data. Methods: New York State clinically appended claims data for AMI were used to create 2 different risk models based on CMS methods: 1 with and 1 without the added clinical data. Model discrimination was compared, and differences between the models in hospital outlier status and tertile status were examined. Results: Mean arterial pressure and heart rate were both significant predictors of mortality in the clinically appended model. The C statistic for the model with the clinical variables added was significantly higher (0.803 vs. 0.773, P<0.001). The model without clinical variables identified 10 low outliers and all of them were percutaneous coronary intervention hospitals. When clinical variables were included in the model, only 6 of those 10 hospitals were low outliers, but there were 2 new low outliers. The model without clinical variables had only 3 high outliers, and the model with clinical variables included identified 2 new high outliers. Conclusion: Appending even a small number of clinical data elements to administrative data resulted in a difference in the assessment of hospital mortality outliers for AMI. The strategy of adding limited but important clinical data elements to administrative datasets should be considered when evaluating hospital quality for procedures and other medical conditions.
Diagnosing Testicular Torsion before Urological Consultation and Imaging: Validation of the TWIST Score
Sheth, Kunj , Keays, Mélise , Grimsby, Gwen M. , Granberg, Candace F. , Menon, Vani S. , DaJusta, Daniel , Ostrov, Lauren , Hill, Martinez, Sanchez, Emma, Kuppermann, David , Harrison, Clanton B., Jacobs, Micah A. , Huang, Rong , Burgu, Berk , Hennes, Halim , Schlomer, Bruce J., Baker, Linda A.

Mayo Clinic

Journal of Urology | February 2, 2016 | Volume: 195 | Issue: 6 | Pages: 1870-1876

10.1016/j.juro.2016.01.101 | PMID 26835833 Get It